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Purpose: While cardiac troponins (C-Tn) are widely used in the emer-
gency room in case of chest pain, there is an increasing rate of prescription of
this test by general practitioners (GPs) in outpatients. Limited data are avai-
lable on the motivations and the issue of C-Tn requested by GPs. We sought
to assess the reasons for C-Tn test prescribed by GPs in our community in
France, and the management of the positive cases.
Methods: We retrospectively retrieved all the C-Tn test requests made by GPs
to the 2 major laboratories in our community of 250,000 inhabitants, within a
period of 4 months. The GPs were contacted by phone to assess their motivations.
Results: During this period, 306 C-Tn tests were requested by 157 GPs.
We excluded 64 cases because of insufficient data. They were comparable to
those included in the study in terms of age, gender, and positive test rates.
Among the 242 cases studied (median age 70 years, 51% males), 41% had ≥3
coronary risk factors. C-Tn was requested because of chest pain in
202 patients (83%). 71% had atypical pain. The prescription was made in
more than 6 and 24 hours after symptom’s onset in 78% and 55% of cases,
respectively. ECG was performed before C-Tn test prescription in only 15%
of cases. In 92% of cases, C-Tn test was negative. Among the 18 positive
cases, 5 (19%) remained at home (3 very old patients, mean age 91 years, and
2 cases considered as false positives). Among the 13 remaining positive cases,
7 were referred directly to cardiologists and 6 to an emergency department.
Among these 13 patients, 11 were referred without medical transportation.
Only 1 patient was transferred medically directly to the cath lab, 24 hours
after chest pain onset.
Conclusion: Cardiac troponin is mainly requested by GPs to exclude acute
coronary syndrome in case of atypical chest pain with delayed consultation.
However, the positivity of this test was useless in 1 out of 5 patients since it
has not changed their management. While in the majority, the C-Tn tests
requested by GPs are negative and avoid hospitalization, the management of
patients with positive test is delayed and not secured. 
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Purpose: Serum Iron (I) is a cofactor of several enzymes, but also, a mediator
of reactive oxygen species production. In literature, the impact of I on prognosis
of patients (P) with Acute Coronary Syndromes (ACS) is not well established.
Methods: Prospective study including 228 P with ACS consecutively
admitted to a coronary care unit over 6 months. P were excluded if they:
didn’t have I measurement (n=26); were under I/erythropoietin supplementa-
tion (n=0); had chronic inflammatory disease (n=8) or malignancy (n=7). 
Results: Pin the lowest Q had higher prevalence of moderate to severe val-
vular disease (10,2% vs 2,2% vs 0%vs 0%; p=0,012) and less frequently pre-
sented with Unstable Angina (0% vs 0% vs 4,3% vs 17,4%; p<0,001). At
admission, they had more often anemia (80,4% vs 58,7% vs 48,8% vs 43,5%;
p=0,014) and signs of heart failure (28,3% vs 24% vs 8,9% vs 8,7%; p=0,004).
They had lower mean corpuscular hemoglobin levels (30,1±2,6 vs 30,7±1,5
vs 30,8±1,5 vs 31,9±3,3g/dL; p=0,002) and higher mean levels of RDW
(13,9±1,3 vs 13,6±1 vs 13,4±1 vs 13,2±0,7%; p=0,008), C reactive protein
(31,7±3856 vs 2199±2769 vs 2137±2550 vs 1167±1900pg/mL; p=0,022).
They had more frequently moderate to severe left ventricular systolic dysfunc-
tion (41,3% vs 28,3% vs 17,4% vs 17,4%; p=0,035). During hospitalization,
2 P died, and we verified a non-significant trend to higher in-hospital mor-
tality in P in the lowest Q (2% vs 2% vs 0% vs 0%). 
The incidence of MACE was significantly higher in the lowest Q (41,7%
vs 31% vs 17,4% vs 10,9%; p=0,002). After multivariate logistic regression,
inclusion of P in the lowest Q persisted as an independent predictor of in-
hospital MACE (OR 4,2; 95% CI 1,27 – 4,45; p=0,019).
Conclusion: Despite the small size of study population, our findings sug-
gest that I may be an independent predictor of in-hospital MACE, with the
lowest I associated with a worse prognosis. A possible trend to increased mor-
tality in this group should be clarified in future studies.
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Background: Risk stratification is a key element to treatment optimization
and prognostic assessment in acute coronary syndromes (ACS). The aim of
the present study was to evaluate and compare the predictive power (PP) of
6 month mortality (6M) of different complete blood count parameters in
patients (P) with ACS.
Methods: Retrospective study including P with ACS consecutively
admitted to a coronary care unit over 4 years and a minimal 6 month follow-
up. In all P the following CBC parameters were evaluated in the first 24 hours:
hemoglobin (Hg), hematocrit (Htc), red blood cell distribution width (RDW)
and platelets (Pl). In a subgroup of 540 P admitted over a 1 year, mean cor-
puscular volume (MCV), mean corpuscular hemoglobin (MCH), leukocytes
(L) and neutrophils (N) were also evaluated.
Results: We included 1906 P (mean age 64±13y; 49,9% with ST-elevation
infarction). The in-hospital mortality was 3,9% and 6M was 8,9%. After cal-
culation of 6M AUC, only Hg (0,712; p<0,001), Htc (0,703; p<0,001) and
RDW (0,622; p=0,05) had PP of 6M. There were no statistically significant
differences between the PP of Hg, Hct and RDW. From the cut-off values
obtained, a multivariate logistic regression model was constructed. Only Hct
and RDW persisted as independent predictors of 6M, with an OR of 3,6 (CI
95%; 2,18-40,43; p<0,001) and 2,8 (CI 95%; 1,04-7,67; p=0,04), respectively.
In a subgroup of P, in addition to previous parameters, L (0,598; p=0,04) and
N (0,619; p=0,014) also had PP of 6M. There were no statistically significant
differences between the PP of Hg, Hct, RDW, L and N, with the exception of
RDW that had a stronger PP than L (p=0.032). After multivariate analysis,
L and N also persisted as independent predictors of 6M, with an OR of 5,1 (CI
95%; 1,42-18,18; p=0,012) and 3,0 (CI 95%; 1,04-8,74; p=0,04), respectively. 
Conclusion: CBC is a routine blood test, which includes parameters that
without extra costs can be helpful in risk stratification of ACS. In the present
study, Hg, Hct, RDW, L and N had PP for 6M in ACS. There were no signi-
ficant differences regarding the PP of 6M between these variables, with the
exception of RWD that had a stronger PP than L.
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Purpose: Stroke is a serious complication after acute myocardial infarc-
tion (AMI) and is associated with an increased risk of death. However, the
increased use of evidence-based therapies (ASA, P2Y12 and statins) has
reduced the risk of stroke during the last decade. Whereas the
pathophysiological mechanisms are not exactly known, increased inflamma-
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tion and platelet reactivity could play an important role in the occurrence of
stroke during the acute phase of MI. We aimed to investigate the relation-
ship between the mean platelet volume (MPV), a parameter of platelet func-
tion, the C-reactive protein (CRP), and the occurrence of in-hospital
ischemic stroke (IHS) after AMI.
Methods: Data were obtained from a French regional survey for AMI,
including 5976 patients admitted in intensive care unit (ICU) between 2001
and 2010. Patients were divided in 2 groups according to the occurrence of
IHS. MPV, platelet count and CRP were routinely measured from blood
samples drawn at admission in ICU.
Results: 87 (1.4%) IHS were recorded during the hospitalization period
after admission for AMI. After Cox multivariate regression, IHS was inde-
pendently associated with history of stroke (OR: 2.26, 95% CI: 1.26-4.06,
p=0.006), LVEF<40% (OR: 1.74, 95% CI: 1.08-2.81, p=0.002), glycemia
(OR: 1.05, 95% CI:1.01-1.08, p=0.008), CRP>10mg/l (OR: 2.56, 95% CI:
1,64-4.01, p<0.001), MPV/Platelet count ratio (OR 1.04, 95% CI: 1.01-1.08,
p=0.03) and new onset atrial fibrillation (OR:1.91, 95% CI:1.12-3.24,
p=0.02). Patients developing IHS had both an increased 30-day mortality
(32.3% vs 8.3%, p<0.001) and 1-year mortality (44.4% vs 13.5%, p<0.001)
(fig.1).
Conclusions: This study describes predictive factors for IHS after AMI,
with both higher short and long-term risk of death. At hospital admission,
new biological parameters as high MPV/Platelet count ratio and high level
of CRP might help to identify patients at increased risk of IHS. Moreover,
these results provide new insights on the potential role played by increased
inflammation and platelet reactivity underlying the occurrence of stroke
after AMI.
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Background & objectives: Small dense LDL particles (sdLDL), with
greater suceptibility to oxydation, are well-recognized risk marker for coro-
nary artery disease (CAD) and type 2 diabetes mellitus. The aim of the present
study sought to separate sdLDL subfraction by heparin-magnesiun precipita-
tion method and to evaluate the possible association of low-density lipoprotein
(LDL) particle size CAD and type 2 diabetes mellitus. 
Methods: Forty eight CAD (with or without type 2 diabetes mellitus)
patients and 51 apparently healthy subjects were included in this study.
sdLDL-cholesterol (sdLDL-C) measured after heparin-magnesiun precipita-
tion. LDL-Cholesterol (LDL-C) was calculated by the Friedwald formula
and large, buoyant LDL-Cholesterol (lrgLDL-C) was estimated by subtrac-
tion. 
Results: The prevalence of sdLDL was strongly related with the CAD risk
level. However, large, buoyant LDL-C showed no significant decrease in
CAD patients. LDL-C decreased significantly in CAD without diabetes
(CADd-) when compared to controls. Its level significantly lower in CAD
with diabetes (CADd+) patients with respect to healthy and to CADd-
patients. Small density LDL-C increased significantly in coronary patients
(with or without diabetes). However, lrgLDL-C was significantly decreased only
in (CADd+) group compared to controls (0.73±0.02 vs 2.02±0.04; p= 0.03
respectively). A negative correlation (r=–0.22, p=0.03) between TG and
sdLDL-C levels was observed when all groups are geathred, and was not
found in controls and CAD patients (with or without diabetes). No correlation
could be evidenced between HDL-C and sdLDL-C concentrations in all
groups nor in CAD group. 
Conclusions: elevated sdLDL-C level may contribute to atherosclerosis
that renforce the developement of coronaropathy. The decrease of lrgLDL
seems to be attribuated to diabetes mellitus rather than to CAD. 
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Backgroud: Serum cystatin C has been proposed as a better marker of glo-
merular filtration rate than serum creatinine. This study aims to evaluate the
relationship between cystatinC, BNP and acute coronary syndrome.
Methods: A total of 127 consecutive patients with acute coronary syn-
drome (ACS) were enrolled in this study. All patients had a normal glomerular
filtration rate (GFR) estimated using the MDRD (Modification of Diet in
Renal Disease) equation.Serum cystatin C and brain natriuretic peptide (BNP)
were determined in all subjects. All patients were followed up for 12 months
and adverse cardiovascular events were recorded.
Results: Serum Cys C levels were significantly higher in patients with
multi-vessel coronary artery disease (1.17±0.47mg/L vs. 0.93±0.24mg/L,
P<0.01). BNP concentrations were significantly associated to left ventricular
ejection fraction (LVEF). Patients with systolic heart failure (LVEF < 50%)
had higher BNP levels (343.3 pg/mL vs. 212.7 pg/mL; P<0.001). Serum Cys
C and BNP levels were significantly associated to mortality and morbidity
post ACS. Receiver operator characteristic (ROC) analyses identified cys C as
being the best marker in predicting major adverse cardiac and cerebrovascular
events (MACCE: heart failure hospitalizations, recurrent ischemic events and
mortality) (AUC=0.622). For high Cys C levels (>1.2mg/L), the risk of occur-
rence of MACCE was multiplied by 3.35 for BNP levels exceeding 350pg/mL.
ROC analyses identified BNP as the best predictor of LV systolic dysfunstion
(AUC = 0.784). A BNP value exceeding 133pg/mL had a sensibility of
83% and a specificity of 67% for predicting LV systolic dysfunction
during follow-up.
Conclusions: Cystatin C and BNP are strong predictors for risk of cardio-
vascular events in acute coronary syndrome. 
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